Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.

Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM.

Psychiatry Res. 2010 Apr 30;176(2-3):109-13. doi: 10.1016/j.psychres.2009.05.004. Epub 2010 Feb 24.

PMID:
20185182
2.

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW.

J Clin Psychiatry. 2006 Mar;67(3):453-60.

PMID:
16649833
3.
4.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group..

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869
5.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
6.

Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.

Haro JM, Suarez D, Novick D, Brown J, Usall J, Naber D; SOHO Study Group..

Eur Neuropsychopharmacol. 2007 Mar;17(4):235-44. Epub 2006 Nov 29.

PMID:
17137759
7.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR.

J Clin Psychiatry. 2006 Jul;67(7):1114-23.

PMID:
16889456
8.

Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.

de Haan L, van Amelsvoort T, Dingemans P, Linszen D.

Pharmacopsychiatry. 2007 Nov;40(6):264-8.

PMID:
18030650
10.

Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.

Novick D, Bousono M, Suarez D, Olivares JM, Montejo AL, Haro JM, Edgell ET, Ratcliffe M; SOHO Advisory Board..

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):972-82.

PMID:
16023776
11.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692
12.

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.

Karagianis J, Novick D, Pecenak J, Haro JM, Dossenbach M, Treuer T, Montgomery W, Walton R, Lowry AJ.

Int J Clin Pract. 2009 Nov;63(11):1578-88. doi: 10.1111/j.1742-1241.2009.02191.x. Epub 2009 Sep 19.

PMID:
19780867
13.

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.

Ascher-Svanum H, Peng X, Faries D, Montgomery W, Haddad PM.

BMC Psychiatry. 2009 Jul 29;9:46. doi: 10.1186/1471-244X-9-46.

14.

Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.

Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.

Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.

PMID:
19672133
15.

Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D.

Psychopharmacology (Berl). 2007 May;191(4):1015-22. Epub 2007 Feb 20.

PMID:
17310386
16.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
17.

Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study.

Gutiérrez-Casares JR, Cañas F, Rodríguez-Morales A, Hidalgo-Borrajo R, Alonso-Escolano D.

CNS Spectr. 2010 May;15(5):327-37.

PMID:
20448523
18.

Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study.

Haro JM, Novick D, Suarez D, Ochoa S, Roca M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1287-92. doi: 10.1016/j.pnpbp.2008.04.003. Epub 2008 Apr 9.

PMID:
18502012
19.

Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

Bitter I, Treuer T, Dyachkova Y, Martenyi F, McBride M, Ungvari GS.

Eur Neuropsychopharmacol. 2008 Mar;18(3):170-80. Epub 2007 Sep 19.

PMID:
17884390
20.

Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.

Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, Huang CF, Wu CC.

Psychiatry Clin Neurosci. 2005 Aug;59(4):403-9.

Supplemental Content

Support Center